JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Hidradenitis Suppurativa in Psoriasis Patients Treated With Biologics

Published online July 20, 2026

To the Editor, While biologic medications are frequently used to treat inflammatory skin diseases, patients have experienced paradoxical skin dis...

read more
Reddit for Redness: A Cross-Sectional Analysis of the r/Rosacea Forum

Published online July 28, 2026

Patients are increasingly turning to social media for disease/treatment advice and support. 1 This has varying benefits 2 but involve...

read more
GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity

Published online July 27, 2026

Psoriasis is a chronic inflammatory skin disorder known to be linked to type 2 diabetes mellitus (T2DM), with 11.6% of psoriasis patien...

read more
Improvement of Rosacea With Tirzepatide: A Case Report

Published online July 28, 2026

Tirzepatide is a dual glucagon-like pedtide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) agonist and is primarily used ...

read more
Impact of Intermittent Fasting, Keto Diet vs Continuous Caloric Restriction on Psoriasis Severity: A Systematic Review and Meta-Analysis Protocol

Published online July 31, 2026

Psoriasis is a chronic immune‑mediated inflammatory skin disease that is strongly associated with metabolic dysregulation and excess ...

read more
Use of an Eczema Moisturizer or Cream Provides Immediate, Sustained Itch Relief in Eczema-Prone Individuals

Published online July 29, 2026

Eczema is a prevalent, chronic skin condition with the highest burden among skin disorders globally, affecting approximately 20% of chi...

read more
Clinical Characteristics and Time to Onset of JAK-Inhibitor–Associated Acne: A Retrospective Chart Review Study

Published online July 29, 2026

Janus kinase (JAK) inhibitors are increasingly prescribed for inflammatory and autoimmune diseases, including atopic dermatitis (AD), a...

read more
Improved Sleep Quality in Psoriasis Patients Under Biologicals: A Prospective Observational Study

Published online July 31, 2026

Psoriatic disease is a common chronic immune-mediated systemic inflammatory disease, most often presenting as chronic plaque psoriasis ...

read more
Molluscum Contagiosum in the Pediatric Population: Expert Consensus Guidance on Prevention and Treatment

Published online July 31, 2026

Molluscum contagiosum (MC), caused by the molluscum contagiosum virus (MCV), is a cutaneous infection that commonly affects children. 1...

read more
Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Pooled Analysis by Age and Sex

Published online July 31, 2026

With an estimated global prevalence of >9% across all ages, acne vulgaris is one of the most common skin disorders. 1 However, acne...

read more
Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial

Published online July 31, 2026

Rosacea is a chronic inflammatory facial skin condition characterized by episodic or persistent erythema, edema, telangiectasias, and/o...

read more
Decreased Nonmelanoma Skin Cancer Risk With Interleukin-17 and Interleukin-23 Inhibitors Versus TNF-α Inhibitors in Psoriasis

Published online July 31, 2026

Psoriasis is a chronic inflammatory condition affecting the skin. 1,2 Pathophysiology involves Th1- and Th17-driven inflammation with ...

read more
Atopic Dermatitis Flare Following Initiation of Nemolizumab

Published online July 27, 2026

Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by intense pruritus and recurrent flares.1 Despite advanc...

read more
GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity

Published online July 27, 2026

Psoriasis is a chronic inflammatory skin disorder known to be linked to type 2 diabetes mellitus (T2DM), with 11.6% of psoriasis patien...

read more
Reining in Medicare Spending on Skin Substitutes: What the 2026 Reforms Mean for Dermatology

Published online July 27, 2026

Medicare Part B spending on skin substitute products rose from $256 million in 2019 to more than $10 billion in 2024. 1 A 2025 brief r...

read more
Speed of Response in Biologic Treatments for Moderate-to-Severe Plaque Psoriasis: Bayesian Network Meta-Analysis

Published online July 20, 2026

Psoriasis is a chronic, immune-mediated inflammatory condition that affects approximately 3% of the adult population in the United Stat...

read more
Assessing Accuracy of ChatGPT in Identifying Contact Allergens in Commonly Prescribed Topical Therapies for Psoriasis

Published online July 20, 2026

To the Editor, Eight percent (8%) of adults are affected by contact allergies. 1 Patch testing is the gold standard for diagnosis of allergic cont...

read more
Comprehensive Analysis of Comorbidities Associated With Psoriasis Diagnosis in the MEPS National Cohort

Published online July 20, 2026

Dear Editor, Psoriasis is recognized as a systemic disease with various comorbidities that increase disease burden and complicate treatment. 1 R...

read more
Risankizumab Associated With Lower Incident Depression and Sleep Disorders in Psoriasis: A TriNetX Study

Published online July 17, 2026

To the Editor, Psoriasis (PsO) is a chronic inflammatory disease associated with significant psychiatric comorbidity. 1 Emerging evidence sugges...

read more
Biologics for Pediatric Hidradenitis Suppurativa: An Update on the Evolving Therapeutic Landscape

Published online July 16, 2026

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by recurrent nodules, abscesses, and sinus tracts th...

read more
Sun Protection: Beyond Sunscreen

Published online July 14, 2026

Ultraviolet (UV) radiation from sun exposure causes photosensitivity, photoaging, and photocarcinogenesis. 1 While dermatologists rout...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

Moringa-Derived Formulations for Hair Growth, Hair Preservation, and Hair Loss: A Systematic Review

| Alopecia, Featured Articles, Hair, Latest News | No Comments
Exploring the Potential of Moringa Formulations in Hair Health and Alopecia Management  Have you read this compelling new systematic review from the Journal of Drugs in Dermatology. As hair loss,…

JDD Re:View With Dr. Beer

| Featured Articles, JDD Re:View, Latest News, Skin of Color | No Comments
Skin of Color: Bridging the Knowledge Gap As the patient population becomes more diverse in the United States, it is becoming increasingly important for dermatologists to be comfortable counseling patients…

La Roche-Posay: Intercepting Melanin Precursors for Next-Generation Dark Spot Correction

| Featured Articles, The Latest, Webinars on Demand | No Comments
Join Janiene Luke, MD, to discover how MELAB3’s breakthrough active, Melasyl (2 MNG), intercepts melanin precursors before they form dark spots, setting a new standard for safety and efficacy across…

New Video Abstract: Efficacy of a Dual-Serum Cosmetic System in Women With Female Pattern Hair Loss

| Featured Articles, The Latest, Video Abstract | No Comments
Hair loss is a widespread condition with a potentially severe psychological burden, especially among women. The chance of suffering from female alopecia increases with menopause, and topical treatments beyond minoxidil…

JDD in the News: Ruxolitinib vs. Triamcinolone for Atopic Dermatitis

| Featured Articles, JDD in the Media, Latest News | No Comments
MedPage Today/Dermatology World Weekly highlighted a Journal of Drugs in Dermatology study comparing a topical JAK inhibitor with a common topical steroid in atopic dermatitis (AD). The study, “Ruxolitinib Cream…

The PASI Paradigm Shift: How Higher Clinical Trial Endpoints Are Reshaping Dermatology

| Dermatology Podcast Archives, Featured Articles, Latest News, Podcast, Podcast Highlights | No Comments
Remember when PASI 75 was the gold medal? Today, it barely makes the podium. In this episode of the JDD Podcast, host Dr. Adam Friedman welcomes Dr. James Song for…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

From Cutaneous Microbiota to Clinical Trial Recruitment… Diversity Matters

| Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Dr. Zoe Draelos Unless you have been under a pile of retention hyperkeratosis, it would be hard to say one has not heard the call to purposefully…
Tune In

Follow Us